A mobile prostate cancer screening program proved feasible for men in underserved neighborhoods and led to a high rate of ...
SAN FRANCISCO -- Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when ...
New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and ...
Combining talazoparib with enzalutamide significantly improves overall survival in patients with metastatic ...
2don MSN
When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the ...
Adding 6 months of neoadjuvant deprivation therapy (NADT) doesn’t seem to add any benefit for patients with intermediate-risk ...
Responses were similar among patients with estrogen patches and ARPIs compared to luteinizing hormone releasing hormone ...
Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of ...
Among those with intermediate-risk prostate cancer, high PSA levels prior to HIFU led to an increased risk of overall ...
A new study by UC San Francisco found that prostate cancer cases are increasing in California, likely due to a change in ...
Untreated prostate cancer can sometimes cause erectile dysfunction (ED). However, ED is more commonly associated with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback